In the open-label study, DMD patients received Satellos’ oral drug for an additional 11 months, following an earlier 28-day trial.
Recently listed, Satellos Bioscience Inc. MSLE on Wednesday reported six-month interim data from its ongoing TRAILHEAD study ...
Key Points Interested in Satellos Bioscience Inc.? Here are five stocks we like better. Satellos Bioscience said its SAT-3247 ...
All four participants showed a decline in fat fraction as measured by MRI, with a mean improvement of 3.7% from 49.7% at TRAILHEAD baseline to ...
Muscle ultrasound helps assess muscle health and its association with motor function in SMA children treated with Spinraza, a ...
A review of instruments used to assess upper-limb function in patients with neuromuscular diseases found that more tools are needed to address specific diseases. In most neuromuscular diseases (NMDs), ...
The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...
August 28, 2009 — The benefits of exercises to strengthen muscles in the upper arms, shoulders, and chest of patients with chronic obstructive pulmonary disease (COPD) extend beyond the upper ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Working muscle groups as a unit is a great way to maximize the benefits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results